Unknown PHASE4 INTERVENTIONAL 2-arm NCT03585426

Vancomycin in the Target Site Treatment of Intracranial Infection

Vancomycin in the Target Site Treatment of Intracranial Infection : a New Strategy for PK/PD Treatment

Sponsor: Xijing Hospital

Interventions Vancomycin

Updated 5 times since 2018 Last updated: Jul 1, 2018 Started: Mar 31, 2016 Primary completion: Dec 31, 2018 Completion: Dec 31, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Vancomycin and is currently ongoing. Xijing Hospital leads this study, which shows 5 recorded versions since 2016 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE4
Jul 2020 — Jan 2021 [monthly]

Unknown Status PHASE4

Status: Enrolling By Invitation → Unknown Status
Aug 2018 — Jul 2020 [monthly]

Enrolling By Invitation PHASE4

First recorded

Mar 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Xijing Hospital

Data source: Xijing Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.